Megan Lutz (@mlutzmd) 's Twitter Profile
Megan Lutz

@mlutzmd

Gastroenterologist @uw_medicine specializing in IBD

ID: 1346941687575228418

calendar_today06-01-2021 22:08:23

9 Tweet

60 Followers

99 Following

UW Division of Gastroenterology & Hepatology (@uw_gihep) 's Twitter Profile Photo

New recommendations from #USPSTF: routine screening for colorectal cancer to start at age 45, down from age 50. Read more about these new recommendations in JAMA JAMA Network ja.ma/3bF5bRw

Carolyn Newberry MD (@cnewberrymd) 's Twitter Profile Photo

I’ve heard these stats before, but still very eye opening 🙍🏽‍♀️ Gender preferences for endoscopists exist among pts, esp women 🙍🏻‍♀️ #CRC screening completion rates are improved when gender specified endoscopist available 🙍🏿‍♀️ Currently, 17.6% of the #GI workforce is female #DDW2021

I’ve heard these stats before, but still very eye opening 
🙍🏽‍♀️ Gender preferences for endoscopists exist among pts, esp women 
🙍🏻‍♀️ #CRC screening completion rates are improved when gender specified endoscopist available 
🙍🏿‍♀️ Currently, 17.6% of the #GI workforce is female 
#DDW2021
Peter Higgins (@ibddoctor) 's Twitter Profile Photo

When a new drug is approved in your field, it is a good practice to go through the prescribing information in detail. There is a *lot* to unpack in the #Ozanimod PI. Let's take a tour (THREAD)

When a new drug is approved in your field, it is a good practice to go through the prescribing information in detail. There is a *lot* to unpack in the  #Ozanimod PI. Let's take a tour (THREAD)
Megan Lutz (@mlutzmd) 's Twitter Profile Photo

Combination therapy is used commonly with vedolizumab and ustekinumab! For ustekinumab, maybe just as commonly as combo with anti-TNF. We need more prospective studies on efficacy and safety of this practice. Read more here: healio.com/news/gastroent… Freddy Caldera, DO, PhD Edward Barnes MD MPH

Freddy Caldera, DO, PhD (@dr_fcalderaibd) 's Twitter Profile Photo

Read our letter to the editor by Megan Lutz. We summarized data regarding J&J immune response. Crohn's & Colitis Foundation ACG AJG - The American Journal of Gastroenterology We should not forget about patients with inflammatory bowel disease who received a COVID-19 viral vector vaccine pubmed.ncbi.nlm.nih.gov/35435853/

Read our letter to the editor by <a href="/MLutzMD/">Megan Lutz</a>.  We summarized data regarding J&amp;J immune response. 
<a href="/CrohnsColitisFn/">Crohn's & Colitis Foundation</a> <a href="/AmCollegeGastro/">ACG</a> <a href="/AmJGastro/">AJG - The American Journal of Gastroenterology</a> 
We should not forget about patients with inflammatory bowel disease who received a COVID-19 viral vector vaccine pubmed.ncbi.nlm.nih.gov/35435853/